ID

16365

Beschreibung

ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment; ODM derived from: https://clinicaltrials.gov/show/NCT00331097

Link

https://clinicaltrials.gov/show/NCT00331097

Stichworte

Versionen (1)
  1. 12.07.16 12.07.16 -
Hochgeladen am

12. Juli 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Breast Cancer NCT00331097

Englisch

Eligibility Breast Cancer NCT00331097

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed invasive unilateral breast cancer
Beschreibung

Invasive carcinoma of breast Unilateral

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0853879
UMLS CUI [1,2]
C0205092
age > 65 and < 80 years
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
intermediate-high risk of recurrence according to st. gallen criteria: er negative and pgr negative, or axillary lymph node metastasis, or tumor size > 2 cm, or tumor grade 2 or 3 (intermediate or high)
Beschreibung

Recurrence High risk Intermediate | Estrogen receptor negative | progesterone receptor negative | AXILLARY LYMPH NODE METASTASIS | Tumor size | TNM clinical staging

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2825055
UMLS CUI [1,2]
C0332167
UMLS CUI [1,3]
C3640764
UMLS CUI [2]
C0279756
UMLS CUI [3]
C0279766
UMLS CUI [4]
C0741344
UMLS CUI [5]
C0475440
UMLS CUI [6]
C3258246
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
performance status >1
Beschreibung

performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1518965
distant metastasis
Beschreibung

Distant metastasis

Datentyp

boolean

Alias
UMLS CUI [1]
C1275402
concomitant malignancy or malignancy within previous 5 years (except basal cell or spinocellular skin cancer and in situ cervical cancer if they have been adequately treated
Beschreibung

Malignant Neoplasms | Basal cell carcinoma Treated Adequate | Spinocellular carcinoma Treated Adequate | Carcinoma in situ of uterine cervix Treated Adequate

Datentyp

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C0007117
UMLS CUI [2,2]
C1522326
UMLS CUI [2,3]
C0205411
UMLS CUI [3,1]
C1168311
UMLS CUI [3,2]
C1522326
UMLS CUI [3,3]
C0205411
UMLS CUI [4,1]
C0851140
UMLS CUI [4,2]
C1522326
UMLS CUI [4,3]
C0205411
previous breast cancer treatment
Beschreibung

Breast Cancer Therapeutic Procedure

Datentyp

boolean

Alias
UMLS CUI [1]
C1511300
neutrophils < 2000/mm3 or platelets < 100000/mm3 or haemoglobin < 10 g/dl
Beschreibung

Absolute neutrophil count | Blood Platelets | Hemoglobin

Datentyp

boolean

Alias
UMLS CUI [1]
C0948762
UMLS CUI [2]
C0005821
UMLS CUI [3]
C0019046
creatinine > 1.25 the upper normal limit
Beschreibung

Creatinine measurement, serum

Datentyp

boolean

Alias
UMLS CUI [1]
C0201976
got and-or gpt and/or bilirubin > 1.25 the upper normal limit
Beschreibung

Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Serum total bilirubin measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0201899
UMLS CUI [2]
C0201836
UMLS CUI [3]
C1278039
concomitant conditions that contraindicate the use of the drugs in the protocol
Beschreibung

Medical contraindication Investigational New Drugs

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0013230
incapacity or refusal to provide informed consent
Beschreibung

Informed Consent Unable | Informed Consent Refused

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1299582
UMLS CUI [2,1]
C0021430
UMLS CUI [2,2]
C1705116
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Breast Cancer NCT00331097

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Invasive carcinoma of breast Unilateral
Item
histologically confirmed invasive unilateral breast cancer
boolean
C0853879 (UMLS CUI [1,1])
C0205092 (UMLS CUI [1,2])
Age
Item
age > 65 and < 80 years
boolean
C0001779 (UMLS CUI [1])
Recurrence High risk Intermediate | Estrogen receptor negative | progesterone receptor negative | AXILLARY LYMPH NODE METASTASIS | Tumor size | TNM clinical staging
Item
intermediate-high risk of recurrence according to st. gallen criteria: er negative and pgr negative, or axillary lymph node metastasis, or tumor size > 2 cm, or tumor grade 2 or 3 (intermediate or high)
boolean
C2825055 (UMLS CUI [1,1])
C0332167 (UMLS CUI [1,2])
C3640764 (UMLS CUI [1,3])
C0279756 (UMLS CUI [2])
C0279766 (UMLS CUI [3])
C0741344 (UMLS CUI [4])
C0475440 (UMLS CUI [5])
C3258246 (UMLS CUI [6])
Item Group
C0680251 (UMLS CUI)
performance status
Item
performance status >1
boolean
C1518965 (UMLS CUI [1])
Distant metastasis
Item
distant metastasis
boolean
C1275402 (UMLS CUI [1])
Malignant Neoplasms | Basal cell carcinoma Treated Adequate | Spinocellular carcinoma Treated Adequate | Carcinoma in situ of uterine cervix Treated Adequate
Item
concomitant malignancy or malignancy within previous 5 years (except basal cell or spinocellular skin cancer and in situ cervical cancer if they have been adequately treated
boolean
C0006826 (UMLS CUI [1])
C0007117 (UMLS CUI [2,1])
C1522326 (UMLS CUI [2,2])
C0205411 (UMLS CUI [2,3])
C1168311 (UMLS CUI [3,1])
C1522326 (UMLS CUI [3,2])
C0205411 (UMLS CUI [3,3])
C0851140 (UMLS CUI [4,1])
C1522326 (UMLS CUI [4,2])
C0205411 (UMLS CUI [4,3])
Breast Cancer Therapeutic Procedure
Item
previous breast cancer treatment
boolean
C1511300 (UMLS CUI [1])
Absolute neutrophil count | Blood Platelets | Hemoglobin
Item
neutrophils < 2000/mm3 or platelets < 100000/mm3 or haemoglobin < 10 g/dl
boolean
C0948762 (UMLS CUI [1])
C0005821 (UMLS CUI [2])
C0019046 (UMLS CUI [3])
Creatinine measurement, serum
Item
creatinine > 1.25 the upper normal limit
boolean
C0201976 (UMLS CUI [1])
Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Serum total bilirubin measurement
Item
got and-or gpt and/or bilirubin > 1.25 the upper normal limit
boolean
C0201899 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
C1278039 (UMLS CUI [3])
Medical contraindication Investigational New Drugs
Item
concomitant conditions that contraindicate the use of the drugs in the protocol
boolean
C1301624 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
Informed Consent Unable | Informed Consent Refused
Item
incapacity or refusal to provide informed consent
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2,1])
C1705116 (UMLS CUI [2,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video